SeriesB

 

Hosted by     Nasdaq 300x150

SERIES B FINANCE RAISE OF THE YEAR

 
This award recognises a company that has successfully completed a significant, impactful or transformational private fundraise at Series B level.
 
It is open to private European life science companies only.

Qualifying criteria

- Must be a fundraise by a private company
- Must have raised the funds in the period between 1 September 2018 and 1 September 2019
- Must be a company with European headquarters

Judges will be paying particular attention to:
 
- Amount of funds raised
- Process / speed / allocation fulfilment of securing of significant new funds
- Level / reputation of investors attracted / reputation of investors reinvesting
- Post-finance allocation / use of proceeds
- Level of value creation / value realisation from raise
 
 

2019 WINNER

 

Exscientia-01-1

 

 

(L-R) Ellie Taylor, Emcee, Mark Swindells, CBO, Exscientia, Aude Echalier, Scientific Coordinator, Exscientia, Mima Pilarova, Executive Assistant, Exscientia, Milly Chen, Commercial Strategy Lead, Exscientia, Millie Britton, Office Manager, Exscientia and Adam Kostyal, SVP, Nasdaq.

 

2019 HIGHLY COMMENDED

Inflazome-01-1

 

ALL 2019 FINALISTS

 

Atlantic Therapeutics

ATLANTIC THERAPEUTICS, IRELAND

Evox Therapeutics

EVOX THERAPEUTICS, UNITED KINGDOM

Exscientia

EXSCIENTIA, UNITED KINGDOM

Imcyse

IMCYSE, BELGIUM

Inflazome

INFLAZOME, IRELAND

Inivata

INIVATA, UNITED KINGDOM

Minoryx Therapeutics

MINORYX THERAPEUTICS, SPAIN

Morphogen-IX

MORPHOGEN-IX, UNITED KINGDOM

BUY TICKETS AND TABLES